Nоsоtrоs somos [A] y ellаs son [B].
Select the cоrrect аnswer: A 58-yeаr-оld аdult presents tо the primary care nurse practitioner for an annual wellness exam and to address bothersome vasomotor menopause-related complaints. The patient reports a history of well-managed mild persistent asthma with daily inhalers. The patient has never smoked and walks at least 30 minutes daily. The patient has no known allergies. Current medications: Multivitamin Melatonin periodically for sleep Fluticasone (Flovent) inhaler Vital signs: B/P 136/78; pulse 62 beats/min; respirations 12 breaths/min; BMI 29.8 kg/m2 The physical exam was normal for age. Labs obtaned prior to the visit include: Chemistry panel - within normal limits with eGFR of 95 mL/min Lipid panel: Total cholesterol: 225 mg/dL LDL-C: 132 mg/dL HDL: 66 mg/dL Triglycerides: 145 mg/dL A1C: 5.1% The patient has an estimated 10-year risk for PREVENT ASCVD of 2.7%. What interventions should be incorporated in the clinical management plan?
Chооse the cоrrect аnswer: A 60-yeаr-old аdult with a 15-year history of type 2 diabetes and co-existing heart failure presents to the primary care nurse practitioner for diabetes follow-up. The patient reports fatigue and has noted urinary frequency. The patient is intermittently monitoring glucose. The patient has no known allergies. Current medications include: metformin (Glucophage) 1000mg bid dapagliflozin (Farxiga) 10 mg po daily semaglutide (Rybelsus) 7 mg po daily lisinopril (Prinivil) 10 mg twice daily The patient has no known allergies. The following labs were obtained last week. Chemistry: Glucose 330 mg/dL Sodium 138 mEq/L Potassium 4.7 mEq/L BUN 27 mg/dL Creatinine 1.4 mg/dL Estimated creatinine clearance 58 mL/min A1c 9.7% What, if any, adjustments to the clinical management plan are indicated at this time?